NRXP
NRx Pharmaceuticals Surpasses Expectations in Q4 2025 Results, Sets Stage for Pivotal Year Ahead
The latest conference call transcript from NRx Pharmaceuticals has revealed a transformative year for the company, with significant advancements in its development programs and a renewed outlook on profitability. Dr. Jonathan Javitt, Founder, Chairman, and CEO of NRx, expressed optimism during the call, stating that 2025 was a "pivotal